International Journal of Colorectal Disease

, Volume 28, Issue 12, pp 1667–1674 | Cite as

Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy

  • Seok-Byung LimEmail author
  • Chang Sik Yu
  • Chan Wook Kim
  • Yong Sik Yoon
  • Seong Ho Park
  • Tae Won Kim
  • Jong Hoon Kim
  • Jin Cheon Kim
Original Article



To identify the indication and prognostic significance of lateral lymph node (LLN) excision in locally advanced rectal cancer patients underwent preoperative chemoradiotherapy.


Included were 67 consecutive patients with suspicious LLN metastasis who underwent chemoradiotherapy and surgery including selective LLN excision (82 excisions). The excisions were grouped according to the presence of LLN metastasis and compared in terms of the clinicopathological findings and oncological results. The correlation between the largest short-axis diameter of LLN measured by imaging and metastasis rates was explored.


LLN metastases were identified in 32 excisions (40.0 %). The calculated short-axis LLN diameter predicting metastasis was 11.7 mm (before chemoradiotherapy) and 11.4 mm (before surgery). LLN metastasis was observed more frequently in the low rectum (p = 0.031) and associated with higher CEA levels (p = 0.048). The 3-year overall survival rates for patients with and without LLN metastasis were 60.3 % and 90.3 % (p = 0.048), while the 3-year disease-free survival rates were 31.4 % and 70.5 % (p = 0.009). The hazard ratio of LLN metastasis for recurrence was 2.938 (95 % CI = 1.258–6.863).


LLN metastasis in rectal cancer patients underwent chemoradiotherapy was a distinct poor prognostic factor. Selective LLN excision based on imaging studies may have a role for such patients.


Preoperative chemoradiotherapy Rectal adenocarcinoma Lateral lymph node 


Conflict of interest

The authors declare no conflicts of interest.


  1. 1.
    Engstrom PF, Arnoletti JP, Benson AB 3rd et al. (2012) The NCCN clinical practice guidelines in oncology, version 4.2012. Available at:
  2. 2.
    Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740PubMedCrossRefGoogle Scholar
  3. 3.
    Garcia-Aguilar J, Cromwell JW, Marra C et al (2001) Treatment of locally recurrent rectal cancer. Dis Colon Rectum 44:1743–1748PubMedCrossRefGoogle Scholar
  4. 4.
    Das P, Skibber JM, Rodriguez-Bigas MA et al (2006) Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 29:219–224PubMedCrossRefGoogle Scholar
  5. 5.
    Hida J, Yasutomi M, Fujimoto K et al (1997) Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method. J Am Coll Surg 184:475–480PubMedGoogle Scholar
  6. 6.
    Takahashi T, Ueno M, Azekura K et al (2000) Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 43(suppl 10):S59–S68PubMedCrossRefGoogle Scholar
  7. 7.
    Ueno H, Mochizuki H, Hashiguchi Y et al (2001) Prognostic determinants of patients with lateral nodal involvement by rectal cancer. Ann Surg 234:190–197PubMedCrossRefGoogle Scholar
  8. 8.
    Kim TH, Jeong SY, Choi DH et al (2008) Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 15:729–737PubMedCrossRefGoogle Scholar
  9. 9.
    Moriya Y, Sugihara K, Akasu T et al (1997) Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 21:728–732PubMedCrossRefGoogle Scholar
  10. 10.
    Enker WE, Thaler HT, Cranor ML et al (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335–346PubMedGoogle Scholar
  11. 11.
    Kusters M, Beets GL, van de Velde CJ et al (2009) A comparison between the treatment of low rectal cancer in Japan and The Netherlands, focusing on the patterns of local recurrence. Ann Surg 249:229–235PubMedCrossRefGoogle Scholar
  12. 12.
    Kim JC, Takahashi K, Yu CS et al (2007) Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Ann Surg 246:754–762PubMedCrossRefGoogle Scholar
  13. 13.
    Hojo K, Koyama Y, Moriya Y (1982) Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 144:350–354PubMedCrossRefGoogle Scholar
  14. 14.
    Kim JH, Beets GL, Kim MJ et al (2004) High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol 52:78–83PubMedCrossRefGoogle Scholar
  15. 15.
    Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19–23PubMedCrossRefGoogle Scholar
  16. 16.
    Youden WJ (1950) Index for rating diagnostic test. Cancer 3:32–35PubMedCrossRefGoogle Scholar
  17. 17.
    Sugihara K, Kobayashi H, Kato T et al (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49:1663–1672PubMedCrossRefGoogle Scholar
  18. 18.
    Sugihara K, Moriya Y, Akasu T et al (1996) Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome. Cancer 78:1871–1880PubMedCrossRefGoogle Scholar
  19. 19.
    Kusters M, Wallner C, Lange MM et al (2010) Origin of presacral local recurrence after rectal cancer treatment. Br J Surg 97:1582–1587PubMedCrossRefGoogle Scholar
  20. 20.
    Konishi T, Watanabe T, Nagawa H et al (2010) Preoperative chemoradiation and extended pelvic lymphadenectomy for rectal cancer: two distinct principles. World J Gastrointest Surg 27:95–100CrossRefGoogle Scholar
  21. 21.
    Nagawa H, Muto T, Sunouchi K et al (2001) Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44:1274–1280PubMedCrossRefGoogle Scholar
  22. 22.
    Williams AD, Cousins C, Soutter WP et al (2001) Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. AJR Am J Roentgenol 177:343–348PubMedCrossRefGoogle Scholar
  23. 23.
    Matsuoka H, Nakamura A, Masaki T et al (2007) Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. Anticancer Res 27:3529–3534PubMedGoogle Scholar
  24. 24.
    Georgiou P, Tan E, Gouvas N et al (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 10:1053–1062PubMedCrossRefGoogle Scholar
  25. 25.
    Yano H, Moran BJ, Watanabe T et al (2010) Lateral pelvic lymph-node dissection: still an option for cure. Lancet Oncol 11:114PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Seok-Byung Lim
    • 1
    Email author
  • Chang Sik Yu
    • 1
  • Chan Wook Kim
    • 1
  • Yong Sik Yoon
    • 1
  • Seong Ho Park
    • 2
  • Tae Won Kim
    • 3
  • Jong Hoon Kim
    • 4
  • Jin Cheon Kim
    • 1
  1. 1.Department of Colon and Rectal SurgeryUniversity of Ulsan College of Medicine and Asan Medical CenterSongpa-guRepublic of Korea
  2. 2.Department of RadiologyUniversity of Ulsan College of Medicine and Asan Medical CenterSeoulRepublic of Korea
  3. 3.Department of OncologyUniversity of Ulsan College of Medicine and Asan Medical CenterSeoulRepublic of Korea
  4. 4.Department of Radiation OncologyUniversity of Ulsan College of Medicine and Asan Medical CenterSeoulRepublic of Korea

Personalised recommendations